NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Agile Therapeutics Inc (F: 0AL)

 
0AL Technical Analysis
4
As on 21st Jun 2022 0AL STOCK Price closed @ 1.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.43 & Strong Sell for SHORT-TERM with Stoploss of 2.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

0ALSTOCK Price

Open 1.10 Change Price %
High 1.10 1 Day -0.06 -5.17
Low 1.10 1 Week -0.21 -16.03
Close 1.10 1 Month 0.95 633.33
Volume N/A 1 Year -1.29 -53.97
52 Week High 4.90 | 52 Week Low 0.10
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
0AL
Daily Charts
0AL
Intraday Charts
Whats New @
Bazaartrend
0AL
Free Analysis
 
0AL Important Levels Intraday
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
 
0AL Forecast December 2024
4th UP Forecast2.47
3rd UP Forecast2.03
2nd UP Forecast1.76
1st UP Forecast1.49
1st DOWN Forecast0.71
2nd DOWN Forecast0.44
3rd DOWN Forecast0.17
4th DOWN Forecast-0.27
 
0AL Weekly Forecast
4th UP Forecast1.31
3rd UP Forecast1.24
2nd UP Forecast1.20
1st UP Forecast1.16
1st DOWN Forecast1.04
2nd DOWN Forecast1.00
3rd DOWN Forecast0.96
4th DOWN Forecast0.89
 
0AL Forecast2024
4th UP Forecast10.37
3rd UP Forecast7.4
2nd UP Forecast5.56
1st UP Forecast3.72
1st DOWN Forecast-1.52
2nd DOWN Forecast-3.36
3rd DOWN Forecast-5.2
4th DOWN Forecast-8.17
 
 
0AL Other Details
Segment EQ
Market Capital 82809560.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
0AL Address
0AL
 
0AL Latest News
 
Your Comments and Response on Agile Therapeutics Inc
 
0AL Business Profile
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. Address: 101 Poor Farm Road, Princeton, NJ, United States, 08540
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service